Page 43 - தேசிய ஆரோக்கியம் ஒழுங்குமுறை அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bahrain approves emergency use of Oxford-AstraZeneca Covid-19 vaccine 0 Comments Get daily business news from the region delivered straight to your inbox I agree to the terms and conditions SIGN UP Covishield is the third vaccine to receive emergency authorisation in Bahrain following Sinopharm and Pfizer-BioNTech January 27, 2021 Bahrain has approved the emergency use of the Oxford-AstraZeneca Covid-19 vaccine, manufactured by the Serum Institute of India under the name Covishield. The decision comes following extensive research conducted by Bahrain’s National Health Regulatory Authority (NHRA) and the Immunization Committee at the Ministry of Health, which considered the results of clinical trials held in several countries as well as information shared by the Serum Institute of India, covering manufacturing processes and batch analyses, the official Bahrain news Agency (BNA) reported.

Maryam athbi al jalahmahOxford astrazeneca covidImmunization committeeBahrain national health regulatory authorityWorld health organizationMinistry of healthSerum institute of indiaSerum instituteNational health regulatory authorityநோய்த்தடுப்பு குழுபஹ்ரைன் தேசிய ஆரோக்கியம் ஒழுங்குமுறை அதிகாரம்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்அமைச்சகம் ஆஃப் ஆரோக்கியம்சீரம் நிறுவனம் ஆஃப் இந்தியாசீரம் நிறுவனம்தேசிய ஆரோக்கியம் ஒழுங்குமுறை அதிகாரம்